MRUS Competitors & Alternatives
Compare Merus BV with similar stocks in the same industry
Biotechnology
MRUS
Main Stock$90.00
Tradestie Score
55
Market Cap
$7.14B
Revenue Growth
0.0%
Analyst Upside
+7.8%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
HALO
Halozyme Therapeutics, Inc.
|
$69.12
|
$8.77B | 25.9 | 62 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$148.46
|
$8.57B | - | 58 | Compare |
|
CAI
Caris Life Sciences, Inc. Common Stock
|
$14.81
|
$8.53B | - | 46 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$231.24
|
$8.30B | 2032.8 | 66 | Compare |
|
CYTK
Cytokinetics Inc.
|
$77.35
|
$6.68B | - | 59 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$94.95
|
$6.64B | - | 59 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$120.86
|
$6.38B | - | 56 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$28.41
|
$6.03B | - | 59 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$50.69
|
$6.02B | - | 54 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$104.71
|
$5.95B | - | 55 | Compare |
More MRUS Analysis
Data updated: May 14, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry